Authors: LUBENOW, N.; EICHLER, P.; LIETZ, T.; GREINACHER, A.

Source: Journal of Thrombosis and Haemostasis, Volume 3, Number 11, November 2005 , pp. 2428-2436(9)

Publisher: Wiley-Blackwell

Abstract:

Summary.

Objectives: To assess efficacy and safety of lepirudin in patients with heparin-induced thrombocytopenia (HIT) in a prospective study (HAT-3) as well as in a combined analysis of all HAT study data. Patients/methods: Patients with laboratory-confirmed HIT were treated with lepirudin in three different aPTT-adjusted dose regimen and during cardiopulmonary bypass (CPB). Endpoints were new thromboembolic complications (TEC), limb amputations, and death and major bleeding. A historical control group (n = 120) was used for comparison. Results: After start of lepirudin in 205 patients treated in HAT-3, the combined endpoint occurred in 43 (21.0%). Thirty (14.6%) patients died, 10 (4.9%) underwent limb amputation, and 11 (5.4%) new TECs occurred. Major bleeding occurred in 40 patients (19.5%) (seven during CPB surgery). Combining all prospective HAT trials (n = 403), after start of lepirudin treatment, the combined endpoint occurred in 82 patients (20.3%), with 47 deaths (11.7%), 22 limb amputations (5.5%), 30 new TECs (7.4%), and 71 (17.6%) major bleedings. Compared with the historical control group (log-rank test), the combined endpoint after start of treatment was reduced (29.7% vs. 52.1%, P = 0.0473), primarily because of reduction in new thromboses (11.9% vs. 32.1%, P = 0.0008). Mean lepirudin maintenance doses ranged from 0.07 to 0.11 mg kg^-1 h^-1. Major bleeding was more frequent in the lepirudin-treated patients (29.4% vs. 9.1%, P = 0.0148). Conclusions: The rate of new TECs in HIT patients is low after start of lepirudin treatment. The rate of major bleeding of 17.6% might be reduced by reducing the starting dose to 0.1 mg kg^-1 h^-1.

Keywords: heparin; hirudin; lepirudin; thrombocytopenia; thrombosis

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1538-7836.2005.01623.x

Publication date: 2005-11-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Allergy & Immunology
• By this author: LUBENOW, N. ;  EICHLER, P. ;  LIETZ, T. ;  GREINACHER, A.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers